Global Health Ltd (ASX:GLH) executive director Mathew Cherian outlintes its strong position to fund growth at Proactive's Lifesciences Webinar on Tuesday, August 10.
He said among the six reasons to invest in the healthcare software stock are its strong outlook for organic revenue growth, with 70-80% ARR, its newly enhanced SaaS platforms ideally suited to the needs of the market place, and its M&A activity in the Asia Pacific Region.